Cycurion (CYCU) announced the closure of five new contracts in September, totaling approximately $1M in value. These agreements are expected to generate an additional $75,000 in monthly recurring revenue, bolstering the company’s growth trajectory. The contracts include four in the healthcare and pharmaceutical industries.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYCU: